首页> 外国专利> Use of compounds that bind to sigma receptor ligands for the treatment of neuropathic pain that develops as a result of chemotherapy

Use of compounds that bind to sigma receptor ligands for the treatment of neuropathic pain that develops as a result of chemotherapy

机译：与sigma受体配体结合的化合物在治疗因化学疗法而引起的神经性疼痛中的用途

页面导航

摘要
著录项
相似文献

摘要

Use of a compound that binds to the sigma receptor for the treatment or prevention of pain that develops as a result of chemotherapy; characterized in that said compound that binds to the sigma receptor has an IC50 value of = 50 nM.

机译：与sigma受体结合的化合物用于治疗或预防因化学疗法而引起的疼痛的用途;其特征在于，所述与σ受体结合的化合物的IC 50值≤50nM。

著录项

公开/公告号ES2665042T3

专利类型
公开/公告日2018-04-24

原文格式PDF
申请/专利权人 LABORATORIOS DEL DR. ESTEVE S.A.;
展开▼

申请/专利号ES20090712762T
发明设计人 BAEYENS-CABRERA JOSÉ MANUEL;BUSCHMANN HELMUT;VELA-HERNANDEZ JOSÉ-MIGUEL;ZAMANILLO-CASTANEDO DANIEL;NIETO-LOPEZ FRANCISCO RAFAEL;
展开▼

申请日2009-02-17
分类号A61K31/137;A61K31/40;A61K31/445;A61K31/4453;A61K31/451;A61K31/4515;A61K31/454;A61K31/46;A61K31/495;A61K31/5415;A61P25/02;A61P29/02;
国家 ES
入库时间 2022-08-21 12:48:36

相似文献

专利
外文文献
中文文献